secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLOBUS MEDICAL INC (GMED)
CIK:        0001237831
Form:       8-K
Filed at:   2023-10-02T23:59:59+00:00
Accession:  0001562762-23-000357
Event type: debt
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Globus Medical enters $400M credit facility, authorizes $350M stock buyback
---------------------------------------------------------------------------

- $400M unsecured credit agreement with U.S. Bank as agent; matures Sept 2028.
- New $350M stock repurchase program approved by board with no time limit.
- About $150.8M remains from prior repurchase programs announced in 2020 and 2022.
- Credit facility includes $200M accordion feature, SOFR-based pricing (margin 1.125%-1.625%).
- Loan parties include NuVasive as guarantor; leverage ratio covenant applies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1237831/000156276223000357/0001562762-23-000357-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1237831/000156276223000357/gmed-20230927x8k.htm
  HTML page:      https://secwatch.observer/filing/0001562762-23-000357

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer